Selective inhibitors of 11 β-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?

Stewart, PM and Tomlinson, JW (2009) Selective inhibitors of 11 β-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both? Diabetes, 58 (1). 14 - 15. ISSN 0012-1797

Metadata

Authors/Creators:
  • Stewart, PM
  • Tomlinson, JW
Copyright, Publisher and Additional Information: (c) 2009, American Diabetes Association. Reproduced in accordance with the publisher's self-archiving policy. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial No Derivates (CC BY-NC-ND 3.0) licence, which permits others to download this work and share it with others, provided the original work is unchanged, properly cited and the use is non-commercial.
Dates:
  • Published: January 2009
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Medicine & Health Faculty Office (Leeds) > Faculty Office Functions (FOMH) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Medicine & Health Faculty Office (Leeds) > Faculty Office Functions (FOMH) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 Nov 2014 10:00
Last Modified: 18 Oct 2017 05:49
Published Version: http://dx.doi.org/10.2337/db08-1404
Status: Published
Publisher: American Diabetes Association
Identification Number: https://doi.org/10.2337/db08-1404
Related URLs:

Share / Export

Statistics